| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/31/2004 | EP1401286A1 Method of inhibiting fungal growth |
| 03/31/2004 | EP1232174A4 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 03/31/2004 | EP1147127A4 Volatilizable solid phase supports for compound synthesis |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/31/2004 | CN1143865C Tumor necrosis factor - ª‡inhibiting peptide and the application thereof |
| 03/31/2004 | CN1143864C Affinity peptide of tumor necrosis factor - ª‡receptor and the application thereof |
| 03/30/2004 | US6713606 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 03/30/2004 | US6713603 Adjusted nucleotide sequences for use as antisense tools in genetic engineering |
| 03/30/2004 | US6713602 Compounds that are not polynucleotides yet which bind to complementary dna and rna strands more strongly the corresponding dna |
| 03/30/2004 | US6713451 Insulin-like growth factor agonist molecules |
| 03/30/2004 | US6713446 Boronic acid compounds obtained by lyophilization of an aqueous mixture of the boronic acid compound and a sugar having at least two hydroxyl groups; shelf life |
| 03/30/2004 | US6713443 Compounds which modify serotoninergic transmission, diagnostic and therapeutic applications |
| 03/30/2004 | US6713301 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 03/30/2004 | US6713266 Immunoassay method for measuring a cyclosporine and its metabolites |
| 03/30/2004 | US6713078 Retrocyclins: antiviral and antimicrobial peptides |
| 03/30/2004 | CA2274144C Somatostatin antagonists |
| 03/25/2004 | WO2004025298A1 Analyzing nerve cell damage |
| 03/25/2004 | WO2004025243A2 A method for the identification of drug targets |
| 03/25/2004 | WO2004024182A2 Method for isolating hepatitis c virus peptides |
| 03/25/2004 | WO2004024173A2 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 03/25/2004 | WO2004024088A2 Design of chemokine analogs for the treatment of human diseases |
| 03/25/2004 | WO2003086326A3 G-type peptides to ameliorate atherosclerosis |
| 03/25/2004 | WO2003074551A3 Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
| 03/25/2004 | WO2003074546A3 Streptavidin-binding peptide |
| 03/25/2004 | WO2003064458A3 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof |
| 03/25/2004 | WO2003057721A3 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 03/25/2004 | WO2003027081A3 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 03/25/2004 | WO2003020749A3 Ncam binding compounds |
| 03/25/2004 | WO2003020215A3 Methods of treating mycocardial event related coditions with thymosin beta 4 |
| 03/25/2004 | WO2003016351A3 N - cam related compounds modulating cell groth |
| 03/25/2004 | WO2003012122A8 Crystallized structure of type iv collagen nc1 domain hexamer |
| 03/25/2004 | WO2002034288A8 Vaccine for treating allergy |
| 03/25/2004 | US20040059088 Short amphipathic peptides with activity against bacteria and intracellular pathogens |
| 03/25/2004 | US20040059087 Peptide nucleic acids |
| 03/25/2004 | US20040058984 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans |
| 03/25/2004 | US20040058876 Secondary binding site of dipeptidyl peptidase IV (DP IV) |
| 03/25/2004 | US20040058874 Synthetic peptide and uses for same |
| 03/25/2004 | US20040058864 Cyclic peptides; three-dimensional structures; screening; anticancer agents; angiogenesis inhibitors; drug delivery |
| 03/25/2004 | US20040058851 Specific autoimmune reactions against isomerised/optically inverted epitopes: application for diagnosis of autoimmune diseases |
| 03/25/2004 | US20040058446 Transfecting cells with nucleic acids; gene therapy |
| 03/25/2004 | US20040058399 Evaluating effectiveness of isoniazid preventive therapy in treating tuberculosis |
| 03/25/2004 | US20040057957 Agent for the treatment and/or prophylaxis of microcirculatory disorders |
| 03/25/2004 | US20040057925 Methods of enhancing bioactivity of chemokines |
| 03/25/2004 | US20040055164 Portable motor-powered shears |
| 03/25/2004 | CA2500462A1 Polyclonal antibodies, preparation method thereof and use of same |
| 03/25/2004 | CA2498723A1 Design of chemokine analogs for the treatment of human diseases |
| 03/25/2004 | CA2498614A1 Analyzing nerve cell damage |
| 03/25/2004 | CA2497890A1 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 03/24/2004 | EP1399740A2 Type 1 diabetes diagnostics and therapeutics |
| 03/24/2004 | EP1399545A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 03/24/2004 | EP1399471A2 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
| 03/24/2004 | EP1399470A2 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 03/24/2004 | EP1399469A2 Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis |
| 03/24/2004 | EP1399180A2 Sulfated ccr5 peptides for hiv-1 infection |
| 03/24/2004 | EP1162991A4 Arginine-rich anti-vascular endothelial growth factor peptides that inhibit growth and metastasis of human tumor cells by blocking angiogenesis |
| 03/24/2004 | EP1124847B1 Lhrh analogues for the treatment of osteoporosis |
| 03/24/2004 | EP0871736B1 PESTICIDAL COMPOSITION COMPRISING CryIF CHIMERIC AND CryIA(c) CHIMERIC BACILLUS THURINGIENSIS DELTA-ENDOTOXIN |
| 03/24/2004 | EP0758341B1 FACTOR Xa INHIBITORS |
| 03/24/2004 | CN1484694A Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 03/24/2004 | CN1484649A Stabilized pharmaceutical composition in lyophilized form |
| 03/24/2004 | CN1484497A Protein hydrol ysater enriched in peptides having a carboxy termina proline residue |
| 03/23/2004 | US6710172 Tumor antigens and CTL clones isolated by a novel procedure |
| 03/23/2004 | US6710165 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
| 03/23/2004 | US6710163 Compounds that bind single-stranded dna and rna strands to form stable hybrids; bind complementary single-stranded dna and rna strands more strongly than corresponding dna |
| 03/23/2004 | US6709814 Dimerization peptides that self-associate |
| 03/23/2004 | US6709649 RANTES derived peptides with anti-HIV activity |
| 03/18/2004 | WO2004022773A1 Fluorescent enzyme assay methods and compositions |
| 03/18/2004 | WO2004022733A1 Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them |
| 03/18/2004 | WO2004022709A2 Epitope sequences |
| 03/18/2004 | WO2004022657A2 Increasing of the resorption of substances via skin and mucous membranes |
| 03/18/2004 | WO2004022101A1 Modified therapeutic agents |
| 03/18/2004 | WO2004022084A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | WO2004011487A3 Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 03/18/2004 | WO2004005925A3 Diagnostics method |
| 03/18/2004 | WO2003094972A3 Fap-activated anti-tumor prodrugs |
| 03/18/2004 | WO2003051272A3 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 03/18/2004 | WO2003033524A3 Peptidyl ketones as inhibitors of dpiv |
| 03/18/2004 | US20040054143 Vegf peptides and their use for inhibiting angiogenesis |
| 03/18/2004 | US20040054131 Receptor binding amino acid sequences for diagnosis and treatment of tumor and neovascularization disorders |
| 03/18/2004 | US20040054130 Insulin potentiating peptides |
| 03/18/2004 | US20040053849 Inhibitors of the E2F-1/cyclin interaction for cancer therapy |
| 03/18/2004 | US20040053847 Suitable for treatment of cancer and for treatment, particularly topical treatment, of infections caused by pathogenic organisms such as bacteria and fungi |
| 03/18/2004 | US20040053844 Peptide and osteogenetic accelerator |
| 03/18/2004 | US20040053828 Partial peptide mimetics and methods |
| 03/18/2004 | US20040053823 Polypeptides with amino acid sequences or peptidomimetics |
| 03/18/2004 | US20040053372 Comprises prothrombin amino acid sequences for treating thrombosis and blood disorders |
| 03/18/2004 | US20040052820 Peptide containing amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178, inhibitory of human and nonhuman retroviral, especially HIV, transmission to uninfected cells |
| 03/18/2004 | US20040052809 Atherosclerosis; apolipoproteins; induce immunology response |
| 03/18/2004 | US20040050782 Solvent extraction to separate impurities; countercurrent fluid flow |
| 03/18/2004 | CA2536795A1 Modified therapeutic agents |
| 03/18/2004 | CA2497991A1 Fluorescent enzyme assay methods and compositions |
| 03/18/2004 | CA2497833A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | CA2497696A1 Increasing the absorption of substances via the skin and mucous membranes |
| 03/18/2004 | CA2496888A1 Epitope sequences |
| 03/18/2004 | CA2496566A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/17/2004 | EP1397486A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 03/17/2004 | EP1397150A2 Somatostatin agonists |
| 03/17/2004 | EP1307609B1 Continuous electrolytic pickling method for metallic products using alternate current supplied cells |
| 03/17/2004 | EP0970107B1 Cyclosporine derivatives and uses thereof |